Medicine

A former Hahnemann residency program director is warning that residents may be left without malpractice insurance to cover their time at the hospital.

The newest faculty member at the Uniformed Services University of the Health Sciences has a great smile ― and likes to be scratched behind the ears.

We look at things that are hard to measure and the different approaches that we take to get those measurements correct.

The first attempt in the United States to use a gene editing tool called CRISPR against cancer seems safe in the three patients who have had it so far.

As the number of teens and pre-teens vaping and using e-cigarettes continues to spike, some 70 hospitals across the state pool information and diagnoses.

The brain waves generated during deep sleep appear to trigger a cleaning system in the brain that protects it against Alzheimer's and other neurodegenerative diseases.

The Philadelphia Department of Prisons has quietly started testing all inmates with hep C and curing those who stay long enough to complete treatment.

Doctors working as forensic investigators help solve some intense murder mysteries.

I ask all the families of my young patients if they are working, staying at home, or in school.

Care for adults with sickle cell disease has lagged behind pediatric care. Some adults may not be well enough to receive cures when they come.

Patients with sickle-cell disease are living longer and a cure could be around the corner. Why doctors in Philadelphia worry those adult patients might be left behind.

The nation's response to the opioid epidemic has been bipartisan, but deep divides have emerged over a settlement plan offered by Purdue Pharma, the maker of Oxycontin.

If Roland Henry had died in a different part of the country, his organs might have been recovered. And lives could have been saved.

Finding the right medication to treat mental health problems can be a frustrating trial-and-error process. New genetic tests aim to match meds to patients, but do they work?

Lawsuits against Purdue Pharma and its owners will be halted for six months in hopes of finalizing a settlement over the OxyContin maker's role in the national opioid crisis.